BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 31011252)

  • 1. Update on hepatocellular carcinoma: Pathologists' review.
    El Jabbour T; Lagana SM; Lee H
    World J Gastroenterol; 2019 Apr; 25(14):1653-1665. PubMed ID: 31011252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
    Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
    Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma.
    Sciarra A; Park YN; Sempoux C
    Hum Pathol; 2020 Feb; 96():48-55. PubMed ID: 31931021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications.
    Berretta M; Cavaliere C; Alessandrini L; Stanzione B; Facchini G; Balestreri L; Perin T; Canzonieri V
    Oncotarget; 2017 Feb; 8(8):14192-14220. PubMed ID: 28077782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology of hepatocellular carcinoma.
    Schlageter M; Terracciano LM; D'Angelo S; Sorrentino P
    World J Gastroenterol; 2014 Nov; 20(43):15955-64. PubMed ID: 25473149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.
    Wang AQ; Zheng YC; Du J; Zhu CP; Huang HC; Wang SS; Wu LC; Wan XS; Zhang HH; Miao RY; Sang XT; Zhao HT
    World J Gastroenterol; 2016 May; 22(18):4459-65. PubMed ID: 27182157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.
    Rastogi A
    World J Gastroenterol; 2018 Sep; 24(35):4000-4013. PubMed ID: 30254404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
    Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC
    Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and treatment trends in hepatocellular carcinoma subtypes: Insights from a national cancer registry.
    Jernigan PL; Wima K; Hanseman DJ; Hoehn RS; Ahmad SA; Shah SA; Abbott DE
    J Surg Oncol; 2015 Dec; 112(8):872-6. PubMed ID: 26603598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
    Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
    J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimensions of hepatocellular carcinoma phenotypic diversity.
    DĂ©sert R; Nieto N; Musso O
    World J Gastroenterol; 2018 Oct; 24(40):4536-4547. PubMed ID: 30386103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma.
    Koh KC; Lee H; Choi MS; Lee JH; Paik SW; Yoo BC; Rhee JC; Cho JW; Park CK; Kim HJ
    Am J Surg; 2005 Jan; 189(1):120-5. PubMed ID: 15701504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular Carcinoma: Histologic Subtypes.
    Shafizadeh N; Kakar S
    Surg Pathol Clin; 2013 Jun; 6(2):367-84. PubMed ID: 26838979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic classification of combined hepatocellular-cholangiocarcinoma.
    Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
    Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on subtypes of hepatocellular carcinoma: From morphology to molecular.
    Vyas M; Jain D
    Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S112-S120. PubMed ID: 34135152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular Carcinoma: Role of Pathology in the Era of Precision Medicine.
    Vyas M; Zhang X
    Clin Liver Dis; 2020 Nov; 24(4):591-610. PubMed ID: 33012447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic histopathology of hepatocellular carcinoma: A case-based review.
    Agni RM
    Semin Diagn Pathol; 2017 Mar; 34(2):126-137. PubMed ID: 28143798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis.
    Park SH; Lee SS; Yu E; Kang HJ; Park Y; Kim SY; Lee SJ; Shin YM; Lee MG
    J Magn Reson Imaging; 2017 Jul; 46(1):267-280. PubMed ID: 27875000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.